Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
Xuesong He,1 Xiao Xue Zeng2 1Department of Cardiology, Changzhou Jintan First People's Hospital, Changzhou City, Jiangsu Province, 213200, People's Republic of China; 2Department of Health Management, Centre of General Practice, The Seventh Affiliated Hospital, Southern Medical University,...
Saved in:
Main Authors: | He X (Author), Zeng XX (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
by: January Salas-Mckee, et al.
Published: (2019) -
The Impact of CRISPR-Cas System on Antiviral Therapy
by: Hadi Bayat, et al.
Published: (2018) -
Optimization of CRISPR-Cas system for clinical cancer therapy
by: Xiang Meng, et al.
Published: (2023) -
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023) -
Bioinformatics investigation of CRISPR/Cas systems in Bifidobacterium longum
by: Amir Zarrinhaghighi, et al.
Published: (2021)